학술논문

Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer
Document Type
Article
Source
In: Oncologist. (Oncologist, December 2023, 28(12):e1209-e1218)
Subject
Language
English
ISSN
1549490X
10837159